Lawrence Kenyon - CEO, Outlook Therapeutics, Inc

As of February 1, 2022


What is Lawrence Kenyon's Net Worth?

The current estimated net worth of Outlook Therapeutics, Inc's CEO, Lawrence Kenyon, is estimated to be about $126.17K . Lawrence Kenyon owns about 18,926 units of Outlook Therapeutics, Inc common stock. In the last 3 years at Outlook Therapeutics, Inc, Lawrence Kenyon has sold an estimated value of $3.13M worth.

What is Lawrence Kenyon's Past Insider Trading?

Lawrence Kenyon's largest purchase order was 25,000 units , worth over $22.38K on February 8, 2019. Lawrence Kenyon's largest sale order was 1,350 units , worth over $2.29K on September 23, 2019. In total, Lawrence Kenyon has made about 9 transactions over 3 years of their time at Outlook Therapeutics, Inc. Lawrence Kenyon usually trades in February, with the busiest year in 2019. The most recent transaction was a purchase order of 10,000 units , worth over $18.3K on April 20, 2021.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Lawrence Kenyon's' Mailing Address?

  • Mailing address is C/o Outlook Therapeutics, Inc. 7 Clarke Drive Cranbury NJ 08512 NJ

What are Outlook Therapeutics, Inc's Past Insider Trades?

Outlook Therapeutics, Inc's most recent insider trade came on June 23, 2022 by Terry Dagnon who bought 10,000 units worth $10.5K . In the last 4 years, insiders at Outlook Therapeutics, Inc have sold an estimated value of $3.49M and bought an estimated value of $63.55M worth of shares. Insider trading is most common in March, with the busiest year in 2020. The most active traders at the company are Kurt Hilzinger, Director,  Ghiath Faisal Sukhtian, Director,  and Arun Pillai Kumar By: Lawrence Kenyon, Attorney-In-Fact, Director .

Outlook Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1